DANAHER CORP /DE/ — fact timeline

DANAHER CORP /DE/ entered into Sixth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at € 3,000,000,000 aggregate principal amount of Senior Notes (effective 2026-04-29).

“On April 29, 2026, Danaher Corporation (“Danaher”) issued € 500,000,000 aggregate principal amount of Floating Rate Senior Notes due 2028 (the “Floating Rate Notes”), € 750,000,000 aggregate principal amount of 3.250% Senior Notes due 2030 (the “2030 Notes”), € 750,000,000 aggregate principal amount of 3.625% Senior Notes due 2034 (the “2034 Notes”) and € 1,000,000,000 aggregate principal amount of 4.000% Senior Notes due 2038 (the “2038 Notes” and, together with the 2030 Notes and the 2034 Notes, the “Fixed Rate Notes” and the Fixed Rate Notes, together with the Floating Rate Notes, the “Notes”), in an underwritten offering pursuant to a registration statement on Form S-3 (File No. 333-278426) filed with the Securities and Exchange Commission (the “Commission”) on April 1, 2024 (the “Registration Statement”) and a preliminary prospectus supplement and prospectus supplement filed with the Commission related to the offering of the Notes. The Notes were issued under that certain indentur”

DANAHER CORP /DE/ reported First quarter 2026 results: revenue $6.0 billion, net income $1.0 billion, EPS $1.45 per diluted common share. Guidance raised.

“were $1.0 billion, or $1.45 per diluted common share. • Non-GAAP adjusted diluted net earnings per common share grew 9.5% to $2.06. • Revenues increased 3.5% year-over-year to $6.0 billion and non-GAAP core revenue increased 0.5% year-over-year. • Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion. • Strong Q1 earnings performance”

DANAHER CORP /DE/ incurred revolving credit of $5.0 billion with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders at Term SOFR plus a margin of between 58.5 and 108.5 basis points maturing April 15, 2027.

“On April 16, 2026, Danaher Corporation (“Danaher”) entered into a new $5.0 billion 364-day revolving credit facility (the “Credit Facility”) with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders from time to time party thereto. The Credit Facility expires on April 15, 2027”

DANAHER CORP /DE/ entered into Credit Agreement with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders valued at $5.0 billion (effective 2026-04-16).

“On April 16, 2026, Danaher Corporation (“Danaher”) entered into a new $5.0 billion 364-day revolving credit facility (the “Credit Facility”) with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders from time to time party thereto.”

DANAHER CORP /DE/: Amended and restated bylaws to revise advance notice and related procedural and disclosure requirements for shareholder proposals and director nominations (effective 2025-09-09).

“On and effective September 9, 2025, the Board of Directors of Danaher Corporation (the “Company”) amended and restated the Company’s Amended and Restated By-laws (as so amended and restated, the “By-laws”) to revise the advance notice and related procedural and disclosure requirements for shareholders to propose business at a meeting of shareholders, including the requirements for the valid nomination of a candidate for director.”

Charles W. Lamanna was appointed as Director at DANAHER CORP /DE/.

“On February 20, 2025, the Board of Directors (“Board”) of Danaher Corporation (“Danaher” or the “Company”) appointed Charles W. Lamanna to the Board, with a term expiring at Danaher’s 2025 annual meeting of shareholders.”

Joakim Weidemanis departed as Executive Vice President at DANAHER CORP /DE/.

“On June 16, 2024, Joakim Weidemanis, Executive Vice President of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he will step down from such position as of July 1, 2024.”

DANAHER CORP /DE/ shareholders rejected Shareholder proposal requesting a report to shareholders on the effectiveness of the Company’s diversity, equity and inclusion efforts at the 2024-05-07 meeting.

“The proposal was rejected by a vote of shareholders as follows: For 88,078,310 Against 537,661,613 Abstain 5,066,360 Broker Non-Votes 33,025,986”

DANAHER CORP /DE/ shareholders rejected Shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 15% at the 2024-05-07 meeting.

“The proposal was rejected by a vote of shareholders as follows: For 271,920,031 Against 357,574,684 Abstain 1,311,568 Broker Non-Votes 33,025,986”

DANAHER CORP /DE/ shareholders approved Approve on an advisory basis the Company’s named executive officer compensation at the 2024-05-07 meeting.

“The proposal was approved by a vote of shareholders as follows: For 586,649,118 Against 41,950,464 Abstain 2,206,701 Broker Non-Votes 33,025,986”

DANAHER CORP /DE/ shareholders approved Ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 at the 2024-05-07 meeting.

“The proposal was approved by a vote of shareholders as follows: For 626,995,788 Against 35,879,628 Abstain 956,853”

DANAHER CORP /DE/ shareholders approved Election of thirteen directors to terms expiring in 2025 at the 2024-05-07 meeting.

“Each nominee for director was elected by a vote of the shareholders as follows: For Against Abstain Broker Non-Votes Rainer M. Blair 617,006,356 13,153,236 646,691 33,025,986 Feroz Dewan 617,006,321 12,629,522 1,170,440 33,025,986 Linda Filler 561,873,256 68,221,238 711,789 33,025,986 Teri List 489,612,702 140,186,350 1,007,231 33,025,986 Jessica L. Mega, MD, MPH 620,823,514 9,340,678 642,091 33,025,986 Mitchell P. Rales 595,648,504 34,352,691 805,088 33,025,986 Steven M. Rales 590,591,256 39,582,134 632,893 33,025,986 Pardis C. Sabeti, MD, D. Phil 593,094,641 37,057,769 653,873 33,025,986 A. Shane Sanders 497,919,918 131,876,005 1,010,360 33,025,986 John T. Schwieters 465,914,759 163,630,380 1,261,144 33,025,986 Alan G. Spoon 541,141,424 88,988,855 676,004 33,025,986 Raymond C. Stevens, PhD 499,219,288 130,608,366 978,629 33,025,986 Elias A. Zerhouni, MD 599,902,732 29,752,439 1,151,112 33,025,986”

DANAHER CORP /DE/ reported the quarter ended March 29, 2024 results: revenue $5.8 billion, net income $1.1 billion, EPS $1.45 per diluted common share.

“earnings were $1.1 billion, or $1.45 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.92. • Revenues decreased 2.5% year-over-year to $5.8 billion and non-GAAP core revenue decreased 4.0%. • Operating cash flow was $1.7 billion and non-GAAP free cash flow was $1.4 billion. Rainer M. Blair, President and Chief Executive”